학술논문
856MO A randomized phase II study of concurrent vs. sequential pembrolizumab with chemoradiation (CRT) in locally advanced head and neck cancer (LA HNSCC): 4-year results and tumor-immune microenvironment analysis
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S557-S558
Subject
Language
ISSN
0923-7534